Mandatory warning sign policies were not associated with reduced cannabis use during pregnancy, nor did they shift opinions regarding risk among those using cannabis prior to pregnancy.
Imagine if we could use machine learning to enhance the care we deliver, analyzing a larger body of patient-specific factors in order to make more reliable predictions of risk for perinatal mood and anxiety disorders.
Evidence suggests that sleep disturbance during pregnancy is associated with higher risk of perinatal depression, especially during the third trimester.
Consistent with other studies, including a large meta-analysis, this study indicates no increased risk of ADHD in offspring following prenatal exposure to antidepressants.
Largest studies to date demonstrate statistically significant risk of preterm birth among women with active PTSD.
Analyzing data from nearly 150,000 children with prenatal antidepressant exposure in two healthcare databases, a recent study finds no association between prenatal exposure to antidepressants and risk for neurodevelopmental disorders.
A recent review and meta-analysis found that upwards of 20% of women with no history of psychiatric illness experience their first bipolar-spectrum mood episode during the perinatal period.
More infants who were exposed to strong agonists and opioids with long half-lives, including methadone, developed neonatal opioid withdrawal syndrome.
While data are limited regarding AEDs and breastfeeding, it appears that none of the AEDs are excreted at high levels into the breast milk, nor have they been associated with high rates of adverse events in the nursing infant.
Family history of psychiatric illness, especially bipolar disorder, was associated with a signifiant increase in risk for postpartum depression.
